HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 04-OCT-18 6MO9 TITLE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 IN COMPLEX WITH N-CYCLOPENTYL-7- TITLE 2 (3,5-DIMETHYLISOXAZOL-4-YL)QUINOLINE-5-SULFONAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: O27.1.1,REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2, KIAA9001, RING3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, EPIGENETIC READER, BROMO DOMAIN, TRANSCRIPTION- KEYWDS 2 TRANSCRIPTION INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.B.LANSDON,Z.E.R.NEWBY REVDAT 3 13-MAR-24 6MO9 1 REMARK REVDAT 2 30-JAN-19 6MO9 1 JRNL REVDAT 1 23-JAN-19 6MO9 0 JRNL AUTH D.SPERANDIO,V.AKTOUDIANAKIS,K.BABAOGLU,X.CHEN,K.ELBEL, JRNL AUTH 2 G.CHIN,B.CORKEY,J.DU,B.JIANG,T.KOBAYASHI,R.MACKMAN, JRNL AUTH 3 R.MARTINEZ,H.YANG,J.ZABLOCKI,S.KUSAM,K.JORDAN,H.WEBB, JRNL AUTH 4 J.G.BATES,L.LAD,M.MISH,A.NIEDZIELA-MAJKA,S.METOBO,A.SAPRE, JRNL AUTH 5 M.HUNG,D.JIN,W.FUNG,E.KAN,G.EISENBERG,N.LARSON,Z.E.R.NEWBY, JRNL AUTH 6 E.LANSDON,C.TAY,R.M.NEVE,S.L.SHEVICK,D.G.BRECKENRIDGE JRNL TITL STRUCTURE-GUIDED DISCOVERY OF A NOVEL, POTENT, AND ORALLY JRNL TITL 2 BIOAVAILABLE 3,5-DIMETHYLISOXAZOLE ARYL-BENZIMIDAZOLE BET JRNL TITL 3 BROMODOMAIN INHIBITOR. JRNL REF BIOORG. MED. CHEM. V. 27 457 2019 JRNL REFN ESSN 1464-3391 JRNL PMID 30606676 JRNL DOI 10.1016/J.BMC.2018.11.020 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7_650 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 38776 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1960 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.0437 - 4.3381 0.96 2714 145 0.1841 0.2227 REMARK 3 2 4.3381 - 3.4443 0.97 2700 143 0.1701 0.1978 REMARK 3 3 3.4443 - 3.0093 0.97 2677 142 0.2023 0.2605 REMARK 3 4 3.0093 - 2.7343 0.98 2669 141 0.2038 0.2193 REMARK 3 5 2.7343 - 2.5383 0.99 2702 142 0.1933 0.2490 REMARK 3 6 2.5383 - 2.3887 0.99 2680 141 0.2010 0.2475 REMARK 3 7 2.3887 - 2.2691 0.99 2709 144 0.1954 0.2457 REMARK 3 8 2.2691 - 2.1704 0.98 2682 143 0.1968 0.2056 REMARK 3 9 2.1704 - 2.0868 0.98 2656 141 0.2016 0.2518 REMARK 3 10 2.0868 - 2.0148 0.97 2655 141 0.2115 0.2613 REMARK 3 11 2.0148 - 1.9518 0.96 2589 138 0.2122 0.2739 REMARK 3 12 1.9518 - 1.8960 0.95 2601 138 0.2137 0.2607 REMARK 3 13 1.8960 - 1.8461 0.93 2525 140 0.2209 0.2472 REMARK 3 14 1.8461 - 1.8011 0.84 2257 121 0.2377 0.2584 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 37.59 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.54950 REMARK 3 B22 (A**2) : -1.87450 REMARK 3 B33 (A**2) : -1.67500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.34190 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 3021 REMARK 3 ANGLE : 0.954 4119 REMARK 3 CHIRALITY : 0.063 423 REMARK 3 PLANARITY : 0.004 518 REMARK 3 DIHEDRAL : 18.062 1172 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MO9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237171. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97741 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 123834 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.27200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG 3350 175MM AMMONIUM SULFATE REMARK 280 100MM HEPES PH8.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 58.00150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.81450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 58.00150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.81450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 236 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 69 REMARK 465 MET A 70 REMARK 465 LYS A 71 REMARK 465 PRO A 72 REMARK 465 GLY A 73 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 SER B 69 REMARK 465 MET B 70 REMARK 465 LYS B 71 REMARK 465 PRO B 72 REMARK 465 GLY B 73 REMARK 465 ARG B 74 REMARK 465 VAL B 75 REMARK 465 GLU B 183 REMARK 465 GLU B 184 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 SER C 69 REMARK 465 MET C 70 REMARK 465 LYS C 71 REMARK 465 PRO C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLN C 182 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 THR B 150 N CA C O CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL B 85 -64.43 -105.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 392 DISTANCE = 6.43 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JVY A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JVY A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JVY B 201 DBREF 6MO9 A 71 194 UNP P25440 BRD2_HUMAN 24 147 DBREF 6MO9 B 71 194 UNP P25440 BRD2_HUMAN 24 147 DBREF 6MO9 C 71 194 UNP P25440 BRD2_HUMAN 24 147 SEQADV 6MO9 SER A 69 UNP P25440 EXPRESSION TAG SEQADV 6MO9 MET A 70 UNP P25440 EXPRESSION TAG SEQADV 6MO9 SER B 69 UNP P25440 EXPRESSION TAG SEQADV 6MO9 MET B 70 UNP P25440 EXPRESSION TAG SEQADV 6MO9 SER C 69 UNP P25440 EXPRESSION TAG SEQADV 6MO9 MET C 70 UNP P25440 EXPRESSION TAG SEQRES 1 A 126 SER MET LYS PRO GLY ARG VAL THR ASN GLN LEU GLN TYR SEQRES 2 A 126 LEU HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN SEQRES 3 A 126 PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS SEQRES 4 A 126 LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO SEQRES 5 A 126 MET ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN SEQRES 6 A 126 TYR TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN SEQRES 7 A 126 THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR SEQRES 8 A 126 ASP ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE SEQRES 9 A 126 PHE LEU GLN LYS VAL ALA SER MET PRO GLN GLU GLU GLN SEQRES 10 A 126 GLU LEU VAL VAL THR ILE PRO LYS ASN SEQRES 1 B 126 SER MET LYS PRO GLY ARG VAL THR ASN GLN LEU GLN TYR SEQRES 2 B 126 LEU HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN SEQRES 3 B 126 PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS SEQRES 4 B 126 LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO SEQRES 5 B 126 MET ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN SEQRES 6 B 126 TYR TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN SEQRES 7 B 126 THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR SEQRES 8 B 126 ASP ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE SEQRES 9 B 126 PHE LEU GLN LYS VAL ALA SER MET PRO GLN GLU GLU GLN SEQRES 10 B 126 GLU LEU VAL VAL THR ILE PRO LYS ASN SEQRES 1 C 126 SER MET LYS PRO GLY ARG VAL THR ASN GLN LEU GLN TYR SEQRES 2 C 126 LEU HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN SEQRES 3 C 126 PHE ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS SEQRES 4 C 126 LEU GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO SEQRES 5 C 126 MET ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN SEQRES 6 C 126 TYR TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN SEQRES 7 C 126 THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR SEQRES 8 C 126 ASP ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE SEQRES 9 C 126 PHE LEU GLN LYS VAL ALA SER MET PRO GLN GLU GLU GLN SEQRES 10 C 126 GLU LEU VAL VAL THR ILE PRO LYS ASN HET JVY A 201 26 HET JVY A 202 26 HET JVY B 201 26 HETNAM JVY N-CYCLOPENTYL-7-(3,5-DIMETHYL-1,2-OXAZOL-4-YL) HETNAM 2 JVY QUINOLINE-5-SULFONAMIDE FORMUL 4 JVY 3(C19 H21 N3 O3 S) FORMUL 7 HOH *251(H2 O) HELIX 1 AA1 THR A 76 VAL A 85 1 10 HELIX 2 AA2 VAL A 85 LYS A 92 1 8 HELIX 3 AA3 ALA A 96 ARG A 100 5 5 HELIX 4 AA4 ASP A 104 GLY A 109 1 6 HELIX 5 AA5 ASP A 112 ILE A 117 1 6 HELIX 6 AA6 ASP A 122 ASN A 132 1 11 HELIX 7 AA7 ALA A 137 ASN A 156 1 20 HELIX 8 AA8 ASP A 160 ALA A 178 1 19 HELIX 9 AA9 ASN B 77 VAL B 85 1 9 HELIX 10 AB1 VAL B 85 LYS B 92 1 8 HELIX 11 AB2 ALA B 96 ARG B 100 5 5 HELIX 12 AB3 ASP B 104 GLY B 109 1 6 HELIX 13 AB4 ASP B 112 ILE B 117 1 6 HELIX 14 AB5 ASP B 122 ASN B 132 1 11 HELIX 15 AB6 ALA B 137 ASN B 156 1 20 HELIX 16 AB7 ASP B 160 ALA B 178 1 19 HELIX 17 AB8 ASN C 77 VAL C 85 1 9 HELIX 18 AB9 VAL C 85 HIS C 93 1 9 HELIX 19 AC1 ALA C 96 ARG C 100 5 5 HELIX 20 AC2 ASP C 112 ILE C 117 1 6 HELIX 21 AC3 ASP C 122 ASN C 132 1 11 HELIX 22 AC4 ALA C 137 ASN C 156 1 20 HELIX 23 AC5 ASP C 160 SER C 179 1 20 SITE 1 AC1 8 GLN A 80 HOH A 355 PRO C 98 PHE C 99 SITE 2 AC1 8 LEU C 108 ASN C 156 ILE C 162 HOH C 215 SITE 1 AC2 13 TRP A 97 PRO A 98 PHE A 99 LEU A 108 SITE 2 AC2 13 LEU A 110 ASN A 156 ILE A 162 MET A 165 SITE 3 AC2 13 HOH A 309 HOH A 349 HOH A 372 HOH A 379 SITE 4 AC2 13 GLN B 94 SITE 1 AC3 10 GLN A 94 TRP B 97 PRO B 98 PHE B 99 SITE 2 AC3 10 LEU B 108 ASN B 156 MET B 165 HOH B 312 SITE 3 AC3 10 HOH B 339 HOH B 361 CRYST1 116.003 55.629 68.340 90.00 95.04 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008620 0.000000 0.000761 0.00000 SCALE2 0.000000 0.017976 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014690 0.00000